JP2025506446A5 - - Google Patents
Info
- Publication number
- JP2025506446A5 JP2025506446A5 JP2024546488A JP2024546488A JP2025506446A5 JP 2025506446 A5 JP2025506446 A5 JP 2025506446A5 JP 2024546488 A JP2024546488 A JP 2024546488A JP 2024546488 A JP2024546488 A JP 2024546488A JP 2025506446 A5 JP2025506446 A5 JP 2025506446A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- pharmaceutically acceptable
- solvate
- acceptable salt
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263306944P | 2022-02-04 | 2022-02-04 | |
| US63/306,944 | 2022-02-04 | ||
| US202263419988P | 2022-10-27 | 2022-10-27 | |
| US63/419,988 | 2022-10-27 | ||
| PCT/US2023/061911 WO2023150663A1 (en) | 2022-02-04 | 2023-02-03 | Certain chemical entities, compositions, and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506446A JP2025506446A (ja) | 2025-03-11 |
| JP2025506446A5 true JP2025506446A5 (enExample) | 2026-02-10 |
Family
ID=87552995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024546488A Pending JP2025506446A (ja) | 2022-02-04 | 2023-02-03 | 特定の化学物質、組成物、および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250145599A1 (enExample) |
| EP (1) | EP4472951A4 (enExample) |
| JP (1) | JP2025506446A (enExample) |
| AU (1) | AU2023216263A1 (enExample) |
| CA (1) | CA3243695A1 (enExample) |
| TW (1) | TW202342444A (enExample) |
| WO (1) | WO2023150663A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120569391A (zh) * | 2023-01-19 | 2025-08-29 | 北京普祺医药科技股份有限公司 | 一种吡唑并环类化合物、药物组合物及其用途 |
| WO2024153237A1 (zh) * | 2023-01-19 | 2024-07-25 | 北京普祺医药科技股份有限公司 | 一种igf-1r酪氨酸激酶抑制剂、药物组合物及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013110585A1 (en) * | 2012-01-23 | 2013-08-01 | Boehringer Ingelheim International Gmbh | 5, 8 -dihydro- 6h- pyrazolo [3, 4 -h] quinazolines as igf-lr/lr inhibitors |
| KR101668574B1 (ko) * | 2012-11-02 | 2016-10-24 | 화이자 인코포레이티드 | 브루톤 티로신 키나제 억제제 |
| CA2913035C (en) * | 2013-05-20 | 2017-08-01 | University Of Washington Through Its Center For Commercialization | 5-aminopyrazole-4-carboxamide inhibitors of cdpk1 |
| KR102404759B1 (ko) * | 2016-05-16 | 2022-05-31 | 쑤저우 시노벤트 파마슈티칼즈 씨오., 엘티디. | Ｂｔｋ 억제제로서의 5-아미노피라졸 카르복사미드 유도체 및 그것의 제조 방법 및 제약학적 조성물 |
-
2023
- 2023-02-03 WO PCT/US2023/061911 patent/WO2023150663A1/en not_active Ceased
- 2023-02-03 AU AU2023216263A patent/AU2023216263A1/en active Pending
- 2023-02-03 TW TW112103888A patent/TW202342444A/zh unknown
- 2023-02-03 EP EP23750422.0A patent/EP4472951A4/en active Pending
- 2023-02-03 JP JP2024546488A patent/JP2025506446A/ja active Pending
- 2023-02-03 CA CA3243695A patent/CA3243695A1/en active Pending
- 2023-02-03 US US18/835,167 patent/US20250145599A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025506446A5 (enExample) | ||
| US10774065B2 (en) | 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2 | |
| US11952386B2 (en) | N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 | |
| JP2019529579A5 (enExample) | ||
| US10301278B2 (en) | 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2 | |
| RU2472509C2 (ru) | Способ лечения артрита | |
| US11414394B2 (en) | Process for producing a hydrate of a hydrochloride salt of 2,2′-((((((2-acetylnaphtho[2,3-b]furan-4,9-diyl)bis(oxy))bis(carbonyl))bis(azanediyl))bis(ethane-2,1-diyl))bis(azanediyl))diacetic acid | |
| JP2023514872A5 (enExample) | ||
| WO2008064116A2 (en) | Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection | |
| TW536401B (en) | A pharmaceutical composition of N,N-bis(phenylcarbamoylmethyl)dimethylammomum chloride and derivatives for the treatment of pain | |
| JP2004525179A5 (enExample) | ||
| JP2004512328A5 (enExample) | ||
| JP2022506111A5 (enExample) | ||
| RU2011103741A (ru) | Композиции и способы лечения заболевания сетчатки | |
| RU99110508A (ru) | 1-фенил-бензимидазольные соединения и их применение в качестве модуляторов гамк-а | |
| ES2414472T3 (es) | Composición farmacéutica de liberación sostenida de acetato de octreotide | |
| JP2005524609A5 (enExample) | ||
| RU2009144538A (ru) | Новые циклические пептидные соединения | |
| JP2022513449A5 (enExample) | ||
| US20100087436A1 (en) | Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection | |
| RU2008102156A (ru) | НОВЫЕ ФУРО- И ТИЕНО[2,3-b]-ХИНОЛИН-2-КАРБОКСАМИДЫ, СПОСОБ ПОЛУЧЕНИЯ И ПРОТИВОТУБЕРКУЛЕЗНАЯ АКТИВНОСТЬ | |
| AR048834A1 (es) | Compuestos derivados de piperidina o tropano; metodos para su preparacion; composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades mediadas por quimioquinas (ccr5) | |
| JP6488000B2 (ja) | ２−シアノ−３−シクロプロピル−３−ヒドロキシ−ｎ−アリール−チオアクリルアミド誘導体 | |
| JP2020519659A5 (enExample) | ||
| RU2015110256A (ru) | Бензофуразановые антимилоидные соединения и способы |